The pathology of bowel cancer screening

Histopathology

Volumn 66, Issue 1, 2015, Pages 66-77

  Loughrey, Maurice B ^a   Shepherd, Neil A ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Adenoma; Colorectal cancer; Epithelial misplacement; Polyp cancer; Pseudo invasion; Screening; Serrated pathology

Indexed keywords

ADENOMATOUS POLYP; CANCER SCREENING; CANCER STAGING; COLON ADENOCARCINOMA; COLON TUMOR; COLORECTAL POLYP; HISTORY OF MEDICINE; HUMAN; INTESTINE CANCER; LARGE SIGMOID COLONIC ADENOMATOUS POLYP; OCCULT BLOOD; PRIORITY JOURNAL; REVIEW; SIGMOID; TUMOR BIOPSY; UNITED KINGDOM; ADENOCARCINOMA; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS;

EID: 84920972656     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12530     Document Type: Review

References (54)

1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, 1968.
2. Lockhart-Mummery JP, Dukes C. The pre-cancerous changes in the rectum and colon. Surg. Gynecol. Obstet. 1928; 46; 591-596.
3. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36; 2251-2270.
4. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112; 594-642.
5. Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967; 201; 943-945.
6. Winawer SJ, Stewart ET, Zauber AG et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N. Engl. J. Med. 2000; 342; 1766-1772.
7. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993; 328; 1365-1371.
8. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348; 1467-1471.
9. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348; 1472-1477.
10. Lansdorp-Vogelaar I, von Karsa L. Immunochemical FOBT: evidence for efficacy. In Senna N, Patnick J, von Karsa L eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: IARC Press, 2010; 14-15.
11. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening. Am. J. Gastroenterol. 2009; 104; 739-750.
12. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand. J. Gastroenterol. 1999; 34; 414-420.
13. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand. J. Gastroenterol. 2003; 38; 635-642.
14. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375; 1624-1633.
15. Winawer SJ, Zauber AG, O'Brien MJ et al. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 1992; 70 (Suppl. S3); 1236-1245.
16. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 2009; 150; 1-8.
17. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J. Natl Cancer Inst. 2010; 102; 89-95.
18. Benson VS, Patnick J, Davies AK et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int. J. Cancer 2008; 122; 1357-1367.
19. Klabunde C, Breen N, Meissner H, Subramanian S. Use of colonoscopy for colorectal cancer screening. Cancer Epidemiol. Biomark. Prev. 2005; 14; 2279-2280.
20. Shepherd NA, Griggs RKL. Bowel cancer screening-generated diagnostic conundrum of the century: pseudo-invasion in sigmoid colonic polyps. Mod. Pathol. 2015; in press.
21. Muto T, Bussey HJR, Morson BC. Pseudocarcinomatous invasion in adenomatous polyps of the colon and rectum. J. Clin. Pathol. 1973; 26; 25-31.
22. Hansen TP, Fenger C, Kronborg O. The expression of p53, Ki-67 and urokinase plasminogen activator receptor in colorectal adenomas with true invasion and pseudoinvasion. APMIS 1999; 107; 689-694.
23. Mueller J, Mueller E, Arras E, Bethke B, Stolte M, Hofler H. Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum. Virchows Arch. 1997; 430; 213-219.
24. Yantiss RK, Bosenberg MW, Antonioli DA, Odze RD. Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Am. J. Surg. Pathol. 2002; 26; 206-215.
25. Yantiss RK, Goldman H, Odze RD. Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases. Mod. Pathol. 2001; 14; 869-875.
26. Cooper HS, Deppisch LM, Kahn EI et al. Pathology of the malignant colorectal polyp. Hum. Pathol. 1998; 29; 15-26.
27. Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am. J. Surg. Pathol. 1983; 7; 613-623.
28. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis. Colon Rectum 2005; 48; 1588-1596.
29. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89; 328-336.
30. Kikuchi R, Takano M, Takagi K et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis. Colon Rectum 1995; 38; 1286-1295.
31. Ueno H, Mochizuki H, Hashiguchi Y et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127; 385-394.
32. Wang HS, Liang WY, Lin TC et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis. Colon Rectum 2005; 48; 1182-1192.
33. Ishii M, Ota M, Saito S, Kinugasa Y, Akamoto S, Ito I. Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int. J. Colorectal Dis. 2009; 24; 1069-1074.
34. Egashira Y, Yoshida T, Hirata I et al. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod. Pathol. 2004; 17; 503-511.
35. Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 2013; 45; 827-834.
36. Loughrey MB, Quirke P, Shepherd NA. Standards and datasets for reporting cancers: dataset for colorectal cancer. 3rd ed. London: Royal College of Pathologists, 2014.
37. Ramirez M, Schierling S, Papaconstantinou HT, Thomas JS. Management of the malignant polyp. Clin. Colon Rectal Surg. 2008; 21; 286-290.
38. Ali SM, Kalla R, Hendrickse M. Endoscopic mucosal resection of large colorectal polyps in non screening colonoscopies has a high recurrence rate. Gut 2013; 62(Suppl. 1); A236.
39. Brooker JC, Saunders BP, Shah SG, Williams CB. Endoscopic resection of large sessile colonic polyps by specialist and non-specialist endoscopists. Br. J. Surg. 2002; 89; 1020-1024.
40. Han KS, Sohn DK, Choi DH et al. Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest. Endosc. 2008; 67; 97-102.
41. Kim EK, Han DS, Kim HS. A biopsy before the colorectal ESD - is it useful? Gastrointest. Endosc. 2012; 75(Suppl. 4); AB407.
42. Hamilton SR, Bosman FT, Boffetta P et al. Carcinoma of the colon and rectum. In Bosman FT, Carneiro F, Hruban RH, Theise ND eds. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010.
43. Quirke P, Risio M, Lambert R, von Karsa L, Vieth M. Quality assurance in pathology in colorectal cancer screening and diagnosis - European recommendations. Virchows Arch. 2011; 458; 1-19.
44. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88; 1739-1757.
45. O'Brien MJ. Serrated pathology. Histopathology 2015; in press.
46. Bateman AC, Shepherd NA. Serrated lesions - nomenclature. British Society of Gastroenterology Serrated Lesion Working Group. 2014, in press.
47. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59; 666-689.
48. Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am. J. Gastroenterol. 2012; 107; 1315-1329.
49. Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader JP, Gonvers JJ. Use, appropriateness, and diagnostic yield of screening colonoscopy: an international observational study (EPAGE). Gastrointest. Endosc. 2006; 63; 1018-1026.
50. Seeff LC, Manninen DL, Dong FB et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 2004; 127; 1661-1669.
51. Moss S, Ancelle-Park R, Brenner H. Chapter 3. Evaluation and interpretation of screening outcomes. In Segnan N, Patnick J, von Karsa L eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: IARC Press, 2010; 71-102.
52. Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne L. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur. J. Cancer Prev. 1991; 1; 49-55.
53. Zorzi M, Falcini F, Fedato C et al. Screening for colorectal cancer in Italy: 2006 survey. Epidemiol. Prev. 2008; 32(Suppl. 1); 55-68.
54. Segnan N, Patnick J, von Karsa L eds. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: IARC Press, 2010.